Clinical Trial

GRIP: Gordian Robotic Integrated Port Closure Study

Study acronym: GRIP
Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
The GRIP (Gordian Robotic Integrated Port Closure) Study is a prospective, single-arm feasibility study evaluating the use of the TroClose™ 1200 device for closure of da Vinci® 12 mm robotic assistant port sites following robotic-assisted surgical procedures. TroClose™ 1200 is an FDA-cleared medical device designed to facilitate fascial closure of laparoscopic and robotic access ports. The device deploys anchors and suture at the beginning of the procedure, allowing closure to be completed at the end of surgery without the need for additional needle passage or specialized closure instruments. The purpose of this study is to assess the safety, feasibility, procedural performance, and clinical outcomes associated with use of the device in patients undergoing robotic-assisted surgery. Study assessments will include successful port-site closure, device-related adverse events, post-operative complications, and short-term follow-up evaluations. Approximately 26 adult participants undergoing robotic-assisted surgical procedures at Allegheny Health Network will be enrolled.
Trial Details
NCT Number NCT07649915
Lead Sponsor Gordian Surgical
Collaborators: Allegheny Health Network, Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute)
Conditions Robotic Surgery
Enrollment 26 participants
Start Date 2026-06-30
Primary Completion 2026-11-30 (estimated)
Study Completion 2026-12-30 (estimated)
Updated on ClinicalTrials.gov 2026-06-16